Revance Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2012 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Revance Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2012 to 2023.
  • Revance Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.37 USD/shares, a 77.3% increase year-over-year.
  • Revance Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.97 USD/shares, a 61.2% increase year-over-year.
  • Revance Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -3.83 USD/shares, a 21.8% increase from 2022.
  • Revance Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -4.9 USD/shares, a 17.5% decline from 2021.
  • Revance Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -4.17 USD/shares, a 14.2% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4 +$1.07 +21.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$5 -$1 -17.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$4 +$0.69 +14.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$5 -$1 -32.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$4 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2015 -$3 +$0.22 +6.79% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-04
2014 -$3 -$4 -377% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-04
2013 $1.17 +$2.54 Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 -$1 Jan 1, 2012 Dec 31, 2012 10-Q 2015-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.